SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PRCY - ANY BODY HAS ANY NEWS ON THESE

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Kenneth E. De Paul who wrote (78)4/17/1997 8:02:00 PM
From: Vip   of 670
 
Kenneth and Chris: I scanned the Annual Report myself. Some issues are:

1.No Research Contract Revenue
2.If and when will Phase III of Tricomin begin?
3.The product is not administered by perscription
4.Is this product in fact unique; one would have to consult a doctor or nurse in the wound care field
5.Company needs approximately $12 million in revenues to break even How long until the company sees signficant sales volume?
6.The Investor Lawsuit was a back-breaker the company needed that $7.5 to fund this increase in sales personnel , production, and promotion
7.Company may need to do a private stock placement within a year in order fund growth which will be shareholder dilution
8.Company needs to partner with a major medical/pharmaceutical company
9.If insiders see light at the end of the tunnel,will they purchase the company's shares at these low prices?

Vip
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext